Notification of Shareholding

RNS Number:7337S
Arana Therapeutics Limited
21 April 2008


For Immediate Release                                             21 April 2008

                           Arana Therapeutics Limited

                          Notification of Shareholding

Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer has identified on 21 April 2008 that Rockwell Securities
Limited has increased its direct holding from 21,424,039 ordinary shares of the
Company (9.11% of the issued share capital of the Company) held as at 25 March
2008 to 23,582,413 ordinary shares of the Company (10.03% of the issued share
capital) as at 18 April 2008.


On 10 April 2008, Lim Sen Yap advised the Australian Securities Exchange (
www.asx.com.au) (ASX) that himself and his associates (as defined under the
Corporations Act 2001 (Australia)) held a total of 27,378,853 ordinary shares in
the Company (11.65% of the issued share capital of the Company) as at 4 April
2008. That notice disclosed Rockwell Securities Limited as the registered holder
of 22,550,556 ordinary shares in the Company.



For further information, please contact:

Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer             [phone]
Niall Henderson, Chief Financial Officer             [phone]

Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich                 [phone]

Nomura Code Securities
Charles Walker                                      [phone]






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLGIGDSLUDGGIB